MedImmune
| Website: | http://www.medimmune.com/ |
| Industry: | Biotechnology |
| Employees: | 1000-9999 |
| Revenue: | $670M+ |
| Headquarters: | Gaithersburg, MD |
Overview
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise. It produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a nasal spray influenza vaccine introduced in 2004.Open Jobs (287)
-
Frederick, MDMar 29
-
Frederick, MDApr 20
-
Gaithersburg, MDMay 04
-
Gaithersburg, MDMay 10
-
Gaithersburg, MDMay 18
-
Gaithersburg, MDMay 18
-
Gaithersburg, MDMay 18
-
Gaithersburg, MDMay 18
-
Gaithersburg, MDMay 18
-
Manhattan, NYApr 26
